SLC25A1 在胶质瘤组织中的表达差异：研究人员分析多个数据库数据及临床样本后发现，与正常脑组织相比，胶质瘤组织中 SLC25A1（线粒体柠檬酸载体）表达显著上调，且高表达与患者预后较差有关。在肿瘤组织中，SLC25A1 蛋白水平也明显高于瘤旁组织和正常脑组织 ...

The MEPED regimen includes nuclear receptor agonists such as pioglitazone and dexamethasone, which counterbalance HL homeostasis, HL stress response inhibitors, everolimus and COX-2 inhibitor, and a ...